King Endowed Professor of Cancer Research

King Endowed Professor of Cancer Research

Rush University Medical Center / Rush University Cancer Center

Chicago, Illinois
 

Rush University Medical Center invites applications for The Robert E. and Emily H. King Endowed Professor of Cancer Research in the Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy. Rush is seeking a Physician Scientist focused on immunotherapy in the treatment of lymphoma and hematologic cancers. The successful candidate will have a demonstrated history of grant funding and an established reputation in the field. In addition, they are Board Certified/Board Eligible and incoming at the associate or professor level. The predominant criteria include: a major commitment to research and scholarly activity that advances the field of medicine, teaching, excellence in clinical care, and institutional service appropriate to the programmatic need the individual is expected to fulfill.

The vision for The Robert E. and Emily H. King Cancer Immunotherapy Research Program is to develop the next generation of cellular and immunologic treatments for hematologic malignancies, setting its sights initially on lymphoma, leukemia, and myeloma.  The central component of the King Cancer Immunotherapy Research Program is the endowed professorship that will support cancer research at Rush in perpetuity. The endowment provides support for laboratory staff and equipment.    

Rush University Medical Center is consistently ranked as one of the nation’s top hospitals by U.S. News & World Report. Rush is ranked in 7 of 16 categories in U.S. News & World Report's 2018-2019 "America's Best Hospitals" issue, and is one of the two top-ranked hospitals in Illinois overall. Rush was one of four hospitals in the country that the American Hospital Association honored for equity of care in June of 2018. Rush was the first hospital in Illinois serving adults and children to receive Magnet status – the highest honor in nursing – and the first in Illinois to earn a fourth four-year designation. Rush has been ranked among the country's top 100 hospitals — and 15 major teaching hospitals — four times by Truven Health Analytics, a leading provider of health care data and analytics. Rush is located short distances from transportation centers, sports facilities, and residential/shopping neighborhoods.

We encourage women and minorities to apply.  Interested candidates, please address your CV and cover letter to:

Timothy M. Kuzel, MD, FACP

The Samuel G. Taylor III, MD, Professor of Oncology

Chief, Division of Hematology, Oncology and Cell Therapy

Rush University Medical Center

 via email to Rose Sprinkle, Manager, Faculty Recruitment at Rose_Sprinkle@rush.edu

Rush is an equal opportunity / Affirmative Action employer